The purpose of this study is to evaluate the effect of colchicine on high sensitivity C-reactive protein (hs-CRP), a blood marker to measure inflammation, in patients with acute coronary syndromes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
80
1mg once daily
1 capsule daily
Hamilton General Hospital
Hamilton, Ontario, Canada
To determine the effect of low dose colchicine on hs-CRP.
Time frame: 30 days
To determine the effect of colchicine on (a)platelet function and (b)short-term risk (30 days) of cardiovascular events
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.